Legal Opinion
Amgen, Inc. v. Hoechst Marion Roussel, Inc.
District Court, D. Massachusetts
Decided January 19, 2001No. 97-10814-WGYPublishedCited by 26 opinions
1Opinion of the Court
FINDINGS, RULINGS, AND ORDER
YOUNG, Chief Judge.
In this jury waived declaratory judgment action, Amgen, Inc. (“Amgen”) seeks a declaration that certain of the patents protecting its best selling drug EPOGEN ® are infringed by the conduct of the defendants, Hoechst Marion Roussel, Inc. and Transkaryotic Therapies, Inc. (collectively “TKT”). TKT denies infringement and, in turn, counterclaims that Amgen’s patents are invalid on a number of grounds.
Amgen, the first to discover and manufacture a recombinant DNA product similar to natural erythropoietin (“EPO”) and useful in various medical…
2Cases cited115 opinions
- Apprendi v. New JerseySupreme Court of the United States · 2000
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
- Graver Tank & Mfg. Co. v. Linde Air Products Co.Supreme Court of the United States · 1950
110 more not listed; retrieve them via the Exa API.
3Cited by26 opinions
- Amgen Inc., Plaintiff-Cross v. Hoechst Marion Roussel, Inc. (Now Known as Aventis Pharmaceuticals, Inc.) and Transkaryotic Therapies, Inc.Court of Appeals for the Federal Circuit · 2003
- Amgen Inc. v. F. Hoffmann-La Roche Ltd.Court of Appeals for the Federal Circuit · 2009
- Astra Aktiebolag v. Andrx Pharmaceuticals, Inc.District Court, S.D. New York · 2002
- Amgen v. Hoechst Marion Roussel (Now Known as Aventis Pharmaceuticals)Court of Appeals for the Federal Circuit · 2006
- 3M Innovative Properties Co. v. Dupont Dow Elastomers LLCDistrict Court, D. Minnesota · 2005
21 more not listed; retrieve them via the Exa API.